The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401).

Phase Iii ◽

Obese Women ◽

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

npj Breast Cancer ◽

10.1038/s41523-017-0040-8 ◽

2017 ◽

Vol 3 (1) ◽

Cited By ~ 32

Author(s):

Jennifer A. Ligibel ◽

William T. Barry ◽

Catherine Alfano ◽

Dawn L. Hershman ◽

Melinda Irwin ◽

...

Keyword(s):

Breast Cancer ◽

Weight Loss ◽

Early Breast Cancer ◽

Study Design ◽

Adjuvant Treatment ◽

Phase Iii ◽

Obese Women ◽

118O Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella

Annals of Oncology ◽

10.1016/j.annonc.2021.08.399 ◽

2021 ◽

Vol 32 ◽

pp. S407-S408

Author(s):

L. Del Mastro ◽

M. Mansutti ◽

G. Bisagni ◽

R. Ponzone ◽

A. Durando ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Early Stage ◽

Phase Iii ◽

Phase III Trial of Concurrent or Sequential Adjuvant Chemoradiotherapy After Conservative Surgery for Early-Stage Breast Cancer: Final Results of the ARCOSEIN Trial

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(07)80366-3 ◽

2007 ◽

Vol 18 (3) ◽

pp. 310-311

Author(s):

A. Recht

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Conservative Surgery ◽

Phase Iii ◽

Adjuvant Chemoradiotherapy ◽

A prospective evaluation of pulmonary, cardiac, and hepatic function (fn) in ‘tAnGo’: A randomized phase III trial of gemcitabine (G) in paclitaxel (T)-containing, epirubicin/cyclophosphamide (EC)-based, adjuvant chemotherapy (CT) for early stage breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.821 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 821-821

Author(s):

C. J. Poole ◽

H. C. Howard ◽

L. Hiller ◽

J. A. Dunn ◽

A. M. Wardley ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Early Stage ◽

Hepatic Function ◽

Phase Iii ◽

Prospective Evaluation ◽

A randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin-based, adjuvant chemotherapy for women with early stage breast cancer

http://isrctn.org/> ◽

10.1186/isrctn51146252 ◽

2013 ◽

Author(s):

Shrushma Loi

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Early Stage ◽

Phase Iii ◽

The Role of Taxanes in the Adjuvant Treatment of Early Stage Breast Cancer

Breast Cancer Research and Treatment ◽

10.1023/a:1024393926965 ◽

2003 ◽

Vol 79 (S1) ◽

pp. 25-34 ◽

Cited By ~ 25

Author(s):

Martine Piccart

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Early Stage ◽

Early Stage Breast Cancer

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

Radiotherapy and Oncology ◽

10.1016/j.radonc.2019.10.014 ◽

2020 ◽

Vol 142 ◽

pp. 52-61 ◽

Cited By ~ 2

Author(s):

Indrajit N. Fernando ◽

Sarah J. Bowden ◽

Kathryn Herring ◽

Cassandra L. Brookes ◽

Ikhlaaq Ahmed ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Phase Iii ◽

Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery of early-stage breast cancer: final results of the ARCOSEIN trial

Cancer/Radiothérapie ◽

10.1016/j.canrad.2007.06.001 ◽

2007 ◽

Vol 11 (4) ◽

pp. 225-226

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Conservative Surgery ◽

Phase Iii ◽

Adjuvant Chemoradiotherapy ◽

UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2018.06.025 ◽

2018 ◽

Vol 103 ◽

pp. 184-194 ◽

Cited By ~ 2

Author(s):

Mario Campone ◽

Magali Lacroix-Triki ◽

Lise Roca ◽

Marc Spielmann ◽

Hans Wildiers ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Poor Prognosis ◽

Early Stage ◽

Phase Iii ◽

In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

Radiotherapy and Oncology ◽

10.1016/j.radonc.2020.01.015 ◽

2020 ◽

Vol 147 ◽

pp. 232

Author(s):

Melis Gultekin ◽

Burak Tilki ◽

Ferah Yildiz

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Phase Iii ◽